Decisions, decisions, decisions: weighing up the evidence for complex interventions
Historically decisions regarding use of new treatments by health providers were simpler: new drugs followed a well-established pathway through phases of clinical trials, whilst other non-pharmacological (complex) interventions were subject to less rigorous evaluation and decisions were more localised. Increasing pressure on budgets and the desire for equity of access have forced a more structured approach to assessment of new interventions. Assessments include a wide range of relevant information, including benefits, harms and monetary costs. Typically, evidence to inform the assessments comes from randomised trial results of efficacy and/or effectiveness, electronic health records and expert judgement. Synthesis of these sources of evidence, along with weak evidence for some treatment effects raises challenges for statisticians and health providers alike. This lecture will use some examples of evaluation of complex interventions to explore a range of issues arising in health provider decision-making.
The lecture can be viewed here
Followed by a drinks reception in the South Courtyard Café